Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia-MedSci.cn

Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia

Xiao, HW; Li, L; Pang, Y; Wu, YB; Jiang, ZJ; Liu, ZH; Wu, JL; Xiao, Y; Huang, F; Liu, QF; Zhang, H; Luo, Y; Huang, H

Xiao, HW (reprint author), Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Hematol, 111 Liuhua Rd, Guangzhou 510010, Guangdong, Peoples R China.; Xiao, HW (reprint author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China

Abstract

We describe the first multicenter prospective study to assess the efficacy, safety, and immune reconstitution of a novel sequential transplant approac......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia

科室

工具

服务